Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics

NK Karamanos, Z Piperigkou, AD Theocharis… - Chemical …, 2018 - ACS Publications
The extracellular matrix (ECM) constitutes a highly dynamic three-dimensional structural
network comprised of macromolecules, such as proteoglycans/glycosaminoglycans …

Role of protein glycosylation in cancer metastasis

L Oliveira-Ferrer, K Legler, K Milde-Langosch - Seminars in cancer biology, 2017 - Elsevier
Although altered glycosylation has been detected in human cancer cells decades ago, only
investigations in the last years have enormously increased our knowledge about the details …

Proteoglycans remodeling in cancer: Underlying molecular mechanisms

AD Theocharis, NK Karamanos - Matrix Biology, 2019 - Elsevier
Extracellular matrix is a highly dynamic macromolecular network. Proteoglycans are major
components of extracellular matrix playing key roles in its structural organization and cell …

Malaria biomimetic for tumor targeted drug delivery

J Pihl, TM Clausen, J Zhou, N Krishnan… - acs Nano, 2023 - ACS Publications
Malaria infected erythrocytes utilize the parasite protein VAR2CSA to bind to a unique
presentation of chondroitin sulfate (CS) for their placenta specific tropism. Interestingly …

The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner

MØ Agerbæk, SR Bang-Christensen, MH Yang… - Nature …, 2018 - nature.com
Isolation of metastatic circulating tumor cells (CTCs) from cancer patients is of high value for
disease monitoring and molecular characterization. Despite the development of many new …

The role of proteoglycans in cancer metastasis and circulating tumor cell analysis

TD Ahrens, SR Bang-Christensen… - Frontiers in cell and …, 2020 - frontiersin.org
Circulating tumor cells (CTCs) are accessible by liquid biopsies via an easy blood draw.
They represent not only the primary tumor site, but also potential metastatic lesions, and …

Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate

EE Vidal-Calvo, A Martin-Salazar, S Choudhary… - Nature …, 2024 - nature.com
Molecular similarities between embryonic and malignant cells can be exploited to target
tumors through specific signatures absent in healthy adult tissues. One such embryonic …

From “serum sickness” to “xenosialitis”: past, present, and future significance of the non-human sialic acid Neu5Gc

C Dhar, A Sasmal, A Varki - Frontiers in immunology, 2019 - frontiersin.org
The description of “serum sickness” more than a century ago in humans transfused with
animal sera eventually led to identification of a class of human antibodies directed against …

The dual role of the glycosaminoglycan chondroitin‐6‐sulfate in the development, progression and metastasis of cancer

A Pudełko, G Wisowski, K Olczyk… - The FEBS Journal, 2019 - Wiley Online Library
The remarkable structural heterogeneity of chondroitin sulfate (CS) and dermatan sulfate
(DS) generates biological information that can be unique to each of these …

Platelet membrane-coated and VAR2CSA malaria protein-functionalized nanoparticles for targeted treatment of primary and metastatic cancer

M Zhou, W Lai, G Li, F Wang, W Liu, J Liao… - … Applied Materials & …, 2021 - ACS Publications
Metastasis is the main cause of death in cancer patients. The efficacy of pharmacological
therapy for cancer is limited by the heterogeneous nature of cancer cells and the lack of …